buprenorphine
Commercial- Indications
- Opioid dependence, Severe pain
Company intelligence / Profile preview
Rusan Pharma
Indiarusanpharma.com ↗
- Ownership
- Private
- Employees
- ~579
- Development stage
- Commercial
01
Overview
Rusan Pharma operates globally with a focus on addiction treatment and pain management. The company manufactures APIs and finished dosage forms including several controlled substances. Its Ankleshwar API facility recently received USFDA GMP approval in May 2024. Products are marketed worldwide with regulatory approvals from major agencies including USFDA, Health Canada, EU authorities, TGA Australia, ANVISA Brazil among others. Key products include buprenorphine/naloxone tablets for opioid dependence (“Addnok-N”), fentanyl patches for pain management—the first of their kind launched in India—and apomorphine for Parkinson’s disease. The pipeline includes both commercialized products and APIs under development.
- Therapeutic areas
- PsychiatryNeurologyInfectious Diseases
- Modalities
- Small molecules (APIs and finished formulations)Transdermal patchesLong acting injectablesCombination products (e.g., buprenorphine + naloxone)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Strategic partnerships in product development/distribution across Europe/Africa/Asia-Pacific.Contract manufacturing partnerships with UK pharma companies.
Beyond the preview
Go deeper on Rusan Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rusan Pharma.